Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02487329
Other study ID # 2015/30-197
Secondary ID
Status Completed
Phase N/A
First received June 22, 2015
Last updated June 26, 2015
Start date January 2015

Study information

Verified date June 2015
Source Near East University, Turkey
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this randomized clinical study was to evaluate the efficiency of Er,Cr:YSGG laser irradiation combined with a resin based tricalcium silicate material and calcium hydroxide (CH) in direct pulp capping for 3 months follow-up period.Sixty permanent vital teeth without symptoms and radiographic changes were randomly assigned to 4 groups (n=15): Gr 1: The exposed area was sealed with CH paste, Gr 2: The treated area was sealed with CH paste following Er,Cr:YSGG laser irradiation at an energy level of 0,5 W without water and 45% air, Gr 3: Resin based tricalcium silicate material (TheraCal LC) was applied directly to the exposed pulp, Gr 4: TheraCal LC was applied following irradiation with Er,Cr:YSGG laser.


Description:

CH is used as gold standard in pulp capping procedures due to its beneficial properties such as induction of mineralization and inhibition of bacterial growth; however tunnel defects and cell inclusions in dentin bridges formed by CH may lead to leakage and bacteria penetration resulting in loss of vitality.

TheraCal LC is a new light-cured, resin-modified, tricalcium silicate based material designed to use for direct and indirect pulp-capping aiming to achieve a bond to composite resins thus reducing micro-leakage.The formulation of TheraCal LC containing tricalcium silicate particles in a hydrophilic monomer provides significant calcium release that stimulates hydroxyapatite and secondary dentin bridge formation The use of laser for direct pulp capping has been suggested for the considerable advantages of lasers including decontamination effect, biostimulation effect, hemostatic and coagulant effect.The erbium, chromium-doped:yttrium, scandium, gallium and garnet (Er,Cr:YSGG) laser which is a relatively new device has been reported to ablate dental hard tissues thanks to its high absorption in water and also strong absorption by the hydroxyl radicals present in the hydroxyapatite structure


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Permanent teeth with deep caries without symptoms

- Vital teeth

- No periapical radiographic changes

- The diameter of the exposed area is between 0,5 mm to 1,5 mm

Exclusion Criteria:

- Spontaneous pain,

- Tenderness to percussion and palpation,

- Bleeding lasting over 3 minute after exposure,

- Periapical radiographic changes such as periradicular or furcal radiolucency, a widened periodontal ligament space and resorption.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Calcium Hydroxide
Exposed area was sealed with a self-hardening calcium hydroxide paste then final restoration was completed using a resin-modified glass ionomer and a nanohybrid composite resin
Er,Cr:YSGG laser + calcium hydroxide
After the exposed area was irradiated with Er,Cr:YSGG laser at an energy level of 0,5 W, a repetition rate of 20 Hz, 140 µs pulse duration with 0% water and 45% air for 10 s, it was sealed with a self-hardening calcium hydroxide paste.Then final restoration was completed using a resin-modified glass ionomer and a nanohybrid composite resin
TheraCal LC
TheraCal LC was applied directly to the exposed pulp with a needle tip syringe in incremental layers that was not to exceed 1 mm in depth. Then final restoration was completed using a resin-modified glass ionomer and a nanohybrid composite resin
Er,Cr:YSGG laser + TheraCal LC
After the exposed area was irradiated with Er,Cr:YSGG laser at an energy level of 0,5 W, a repetition rate of 20 Hz, 140 µs pulse duration with 0% water and 45% air for 10 s, TheraCal LC was used to seal the treated area. Then final restoration was completed using a resin-modified glass ionomer and a nanohybrid composite resin

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Near East University, Turkey

References & Publications (2)

Olivi G, Genovese MD, Maturo P, Docimo R. Pulp capping: advantages of using laser technology. Eur J Paediatr Dent. 2007 Jun;8(2):89-95. — View Citation

Yazdanfar I, Gutknecht N, Franzen R. Effects of diode laser on direct pulp capping treatment : a pilot study. Lasers Med Sci. 2015 May;30(4):1237-43. doi: 10.1007/s10103-014-1574-8. Epub 2014 Apr 23. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pulp vitality Pulp vitality is assessed with electric pulp tester as vital or non-vital 3 months No
Primary Assessment of pain with questionnaire Pain assessment is carried out using the pain Numerical Rating Scale (NRS) with ratings between 0 to 9. No reactions to thermal stimuli and no tenderness to percussion. 3 months No
Secondary Radiographic success No signs of root resorption (internal or external), no signs of furcation involvement or periapical radiolucency, no signs of loss of lamina dura, no widened periodontal ligament space 3 months No
See also
  Status Clinical Trial Phase
Completed NCT02019563 - MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial Phase 2
Completed NCT00812877 - Pulp Capping With Two Different Agents N/A
Not yet recruiting NCT04330768 - Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial N/A
Completed NCT02789423 - Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth N/A
Completed NCT01468480 - Human Pulpal Response After Pulp Capping With Four Different Agents Phase 2/Phase 3
Completed NCT00187850 - The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy N/A
Completed NCT03631511 - Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA N/A
Completed NCT02492841 - Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth Phase 2/Phase 3